Omega Diagnostics Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Omega Diagnostics Ltd. - overview
Established
1987
Location
-, -, UK
Primary Industry
Medical Devices & Equipment
About
Founded in 1987 and based in the UK, Omega Diagnostics Ltd. operates as a provider of Visitect CD4, a diagnostic device used for monitoring immune and clinical status for patients with HIV diseases.
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment
Website
www.omegadiagnostics.com
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Omega Diagnostics Ltd. - timeline of key events
Omega Diagnostics Ltd. - financials
| Fiscal Year Ended | Mar 31, 2011 | Mar 31, 2012 | Mar 31, 2013 | Mar 31, 2014 | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | Mar 31, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 2,564,203 | 2,589,897 | 2,512,733 | 2,347,419 | 2,397,933 | 2,375,952 | 2,487,980 | 2,427,421 | 8,696,228 | 9,395,987 | 8,510,621 | 8,248,000 | - | - | - |
| % Revenue Growth (YoY) | - | 1.0% | (3.0%) | (6.6%) | 2.2% | (0.9%) | 4.7% | (2.4%) | 258.2% | 8.0% | (9.4%) | (3.1%) | - | - | - |
| EBITDA (USD) | 249,324 | 216,154 | 146,852 | 196,178 | 153,743 | 187,782 | (35,562) | (858,471) | 1,362,388 | 2,883,100 | (2,595,186) | 455,000 | - | - | - |
| Operating Income (USD) | 229,182 | 181,624 | 82,376 | 124,390 | 88,665 | 125,418 | (104,647) | (932,968) | 1,028,366 | 1,834,258 | (3,368,875) | (544,000) | - | - | - |
| Operating Margin | 8.9% | 7.0% | 3.3% | 5.3% | 3.7% | 5.3% | (4.2%) | (38.4%) | 11.8% | 19.5% | (39.6%) | (6.6%) | - | - | - |
| % EBITDA Margin | 9.7% | 8.3% | 5.8% | 8.4% | 6.4% | 7.9% | (1.4%) | (35.4%) | 15.7% | 30.7% | (30.5%) | 5.5% | - | - | - |
| NET Income (USD) | 154,558 | 186,864 | 136,270 | 151,164 | 157,265 | (168,856) | (354,606) | (687,306) | 817,973 | 2,912,510 | (2,527,601) | (10,399,000) | - | - | - |
| % Net Margin | 6.0% | 7.2% | 5.4% | 6.4% | 6.6% | (7.1%) | (14.3%) | (28.3%) | 9.4% | 31.0% | (29.7%) | (126.1%) | - | - | - |
Omega Diagnostics Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Unspecified Exit | Completed | Omega Diagnostics Ltd. | - | ||||||||
| PIPE | Completed | Omega Diagnostics Ltd. | - |
Displaying 1 - 2 of 2
Omega Diagnostics Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.